AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Present Heart Attack Detection Pilot Study Results at TCT 2026
HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care, announced that results from its ALIGN-ACS pilot study evaluating its 3D electrocardiogram ("ECG") technology for heart attack assessment will be presented at the Transcatheter Cardiovascular Therapeutics ("TCT") 2026 conference in San Diego. The presentation, scheduled for Nov. 1 at 1:20 p.m. Pacific time, will be delivered by Dr. Graham Nichol of the University of Washington. The study enrolled 132 emergency department patients presenting with chest pain at two clinical sites in Belgrade, Serbia, and compared the HeartBeam System, a credit card-sized, three-lead device, with a standard 12-lead ECG for…